Management of pulmonary hypertension
Pulmonary arterial hypertension (PAH) is a potentially lethal disease mainly affecting young females. Although the precise mechanism of PAH is unknown, the past decade has seen the advent of many new classes of drugs with improvement in the overall prognosis of the disease. Unfortunately the therapeutic options for PAH in South Africa are severely limited. The Working Group on PAH is a joint effort by the South African Heart Association and the South African Thoracic Society tasked with improving the recognition and management of patients with PAH. This article provides a brief summary of the disease and the recommendations of the first meeting of the Working Group.
Saved in:
Main Authors: | Essop,M R, Galie,N, Badesch,D B, Lalloo,U, Mahomed,A G, Naidoo,D P, Ntsekhe,M, Williams,P G |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
South African Medical Association
2015
|
Online Access: | http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742015000600009 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Scleroderma and pulmonary hypertension
by: Fagan,Karen A., et al.
Published: (2003) -
Pulmonary hypertension and pulmonary artery dissection
by: Corrêa,Ricardo de Amorim, et al.
Published: (2013) -
Effect of pulmonary hypertension on outcome of pulmonary tuberculosis
by: Marjani,Majid, et al.
Published: (2014) -
Pulmonary capillary hemangiomatosis: an uncommon cause of pulmonary hypertension
by: Faria,Igor Murad, et al.
Published: (2013) -
Pulmonary hypertension in schistosomiasis mansoni
by: Lambertucci,José Roberto, et al.
Published: (2006)